Cell-Free DNA Methylation Profiling Analysis—Technologies and Bioinformatics

Analysis of circulating nucleic acids in bodily fluids, referred to as “liquid biopsies”, is rapidly gaining prominence. Studies have shown that cell-free DNA (cfDNA) has great potential in characterizing tumor status and heterogeneity, as well as the response to therapy and tumo...

Full description

Bibliographic Details
Main Authors: Jinyong Huang, Liang Wang
Format: Article
Language:English
Published: MDPI AG 2019-11-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/11/11/1741
id doaj-a69909bf13514eb09f59820799e05048
record_format Article
spelling doaj-a69909bf13514eb09f59820799e050482020-11-25T02:03:10ZengMDPI AGCancers2072-66942019-11-011111174110.3390/cancers11111741cancers11111741Cell-Free DNA Methylation Profiling Analysis—Technologies and BioinformaticsJinyong Huang0Liang Wang1Department of Tumor Biology, H. Lee Moffitt Cancer Center, Tampa, Florida 33612, USADepartment of Tumor Biology, H. Lee Moffitt Cancer Center, Tampa, Florida 33612, USAAnalysis of circulating nucleic acids in bodily fluids, referred to as “liquid biopsies”, is rapidly gaining prominence. Studies have shown that cell-free DNA (cfDNA) has great potential in characterizing tumor status and heterogeneity, as well as the response to therapy and tumor recurrence. DNA methylation is an epigenetic modification that plays an important role in a broad range of biological processes and diseases. It is well known that aberrant DNA methylation is generalizable across various samples and occurs early during the pathogenesis of cancer. Methylation patterns of cfDNA are also consistent with their originated cells or tissues. Systemic analysis of cfDNA methylation profiles has emerged as a promising approach for cancer detection and origin determination. In this review, we will summarize the technologies for DNA methylation analysis and discuss their feasibility for liquid biopsy applications. We will also provide a brief overview of the bioinformatic approaches for analysis of DNA methylation sequencing data. Overall, this review provides informative guidance for the selection of experimental and computational methods in cfDNA methylation-based studies.https://www.mdpi.com/2072-6694/11/11/1741liquid biopsiescell-free dnadna methylationbioinformaticnext-generation sequencing
collection DOAJ
language English
format Article
sources DOAJ
author Jinyong Huang
Liang Wang
spellingShingle Jinyong Huang
Liang Wang
Cell-Free DNA Methylation Profiling Analysis—Technologies and Bioinformatics
Cancers
liquid biopsies
cell-free dna
dna methylation
bioinformatic
next-generation sequencing
author_facet Jinyong Huang
Liang Wang
author_sort Jinyong Huang
title Cell-Free DNA Methylation Profiling Analysis—Technologies and Bioinformatics
title_short Cell-Free DNA Methylation Profiling Analysis—Technologies and Bioinformatics
title_full Cell-Free DNA Methylation Profiling Analysis—Technologies and Bioinformatics
title_fullStr Cell-Free DNA Methylation Profiling Analysis—Technologies and Bioinformatics
title_full_unstemmed Cell-Free DNA Methylation Profiling Analysis—Technologies and Bioinformatics
title_sort cell-free dna methylation profiling analysis—technologies and bioinformatics
publisher MDPI AG
series Cancers
issn 2072-6694
publishDate 2019-11-01
description Analysis of circulating nucleic acids in bodily fluids, referred to as “liquid biopsies”, is rapidly gaining prominence. Studies have shown that cell-free DNA (cfDNA) has great potential in characterizing tumor status and heterogeneity, as well as the response to therapy and tumor recurrence. DNA methylation is an epigenetic modification that plays an important role in a broad range of biological processes and diseases. It is well known that aberrant DNA methylation is generalizable across various samples and occurs early during the pathogenesis of cancer. Methylation patterns of cfDNA are also consistent with their originated cells or tissues. Systemic analysis of cfDNA methylation profiles has emerged as a promising approach for cancer detection and origin determination. In this review, we will summarize the technologies for DNA methylation analysis and discuss their feasibility for liquid biopsy applications. We will also provide a brief overview of the bioinformatic approaches for analysis of DNA methylation sequencing data. Overall, this review provides informative guidance for the selection of experimental and computational methods in cfDNA methylation-based studies.
topic liquid biopsies
cell-free dna
dna methylation
bioinformatic
next-generation sequencing
url https://www.mdpi.com/2072-6694/11/11/1741
work_keys_str_mv AT jinyonghuang cellfreednamethylationprofilinganalysistechnologiesandbioinformatics
AT liangwang cellfreednamethylationprofilinganalysistechnologiesandbioinformatics
_version_ 1724948962383757312